Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience, health risks, and extreme weather.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts degree in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

Tiny, 3-D clusters of human brain cells grown in a petri dish are providing hints about the origins of disorders like autism and epilepsy.

An experiment using these cell clusters — which are only about the size of the head of a pin — found that a genetic mutation associated with both autism and epilepsy kept developing cells from migrating normally from one cluster of brain cells to another, researchers report in the journal Nature.

People with a brain injury or dementia often struggle to remember simple things, like names or places. In research published Thursday in the journal Current Biology, scientists have shown it may be possible to improve this sort of memory using tiny pulses of electricity — if they're properly timed.

A typical person's ability to remember things tends to vary a lot, says Michael Kahana, who directs the computational memory lab at the University of Pennsylvania.

Most of us have about five dreams each night, though we're not likely to remember any of them.

But a team of researchers has found a pattern of brain activity that seems to reveal not only when the brain is generating a dream but something about the content of that dream.

The U.S. military is trying to figure out whether certain heavy weapons are putting U.S. troops in danger.

The concern centers on the possibility of brain injuries from shoulder-fired weapons like the Carl Gustaf, a recoilless rifle that resembles a bazooka and is powerful enough to blow up a tank.

A paralyzed man has regained the use of his arm and hand using a system that decodes his thoughts and controls his muscles.

Gerard Sanacora, a professor of psychiatry at Yale University, has treated hundreds of severely depressed patients with low doses of ketamine, an anesthetic and popular club drug that isn't approved for depression.

This sort of "off-label" prescribing is legal. But Sanacora says other doctors sometimes ask him, "How can you be offering this to patients based on the limited amount of information that's out there and not knowing the potential long-term risk?"

Sanacora has a simple answer.

Scientists are hoping that a single drug can treat two devastating brain diseases: Parkinson's and Alzheimer's.

The drug is nilotinib, which is approved to treat a form of leukemia.

Pages